Nexo Therapeutics
Littleton
About Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $60.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2023)
- Website: nexotx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/nexo-therapeutics-127635 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.